Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
About this item
Full title
Author / Creator
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne: John Wiley & Sons Australia, Ltd
Subjects
More information
Scope and Contents
Contents
Background
Febrile neutropenia (FN) during cancer chemotherapy can lead to morbidity and mortality. The Multinational Association of Supportive Care in Cancer (MASCC) and clinical index of stable febrile neutropenia (CISNE) scores have been widely used to predict the risk of severe medical complications in patients with FN; however, there are fe...
Alternative Titles
Full title
Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e22ee558aa294d0188ae602634a3cc6b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e22ee558aa294d0188ae602634a3cc6b
Other Identifiers
ISSN
1759-7706
E-ISSN
1759-7714
DOI
10.1111/1759-7714.14720
